I Mab Adr (IMAB)

Jul 17, 2025

I-Mab acquires Bridge Health to strengthen givastomig development By Investing.com - Investing.com South Africa

Jul 17, 2025

Jul 17, 2025

I-Mab acquires Bridge Health to strengthen givastomig development - Investing.com India

Jul 17, 2025

Jul 16, 2025

Best Income Stocks to Buy for July 16th - The Globe and Mail

Jul 16, 2025

Jul 14, 2025

I-Mab to Present at the BTIG Virtual Biotechnology Conference - GlobeNewswire Inc.

Jul 14, 2025

Jul 11, 2025

I-MAB files 6-K to amend US$21M ADS shelf registration | BQ SEC FilingForm 6-K - Stock Titan

Jul 11, 2025

Jul 02, 2025

I-Mab reports 83% response rate for givastomig in gastric cancer study - Investing.com India

Jul 02, 2025

Jun 30, 2025

I-Mab’s givastomig shows promising results in gastric cancer study - Investing.com

Jun 30, 2025

Jun 27, 2025

I-Mab stock maintains buy rating at H.C. Wainwright on strong cancer data - Investing.com

Jun 27, 2025

Jun 26, 2025

I-Mab reports 71% response rate for gastric cancer drug in trial - Investing.com

Jun 26, 2025

Jun 24, 2025

H.C. Wainwright reiterates buy rating on I-Mab stock ahead of key data - Investing.com

Jun 24, 2025

Jun 17, 2025

I-Mab at H.C. Wainwright: Strategic Shift Towards U.S. Operations - Investing.com

Jun 17, 2025

Jun 17, 2025

I-Mab at H.C. Wainwright: Strategic Shift Towards U.S. Operations By Investing.com - Investing.com South Africa

Jun 17, 2025

Jun 17, 2025

Market Momentum: Abpro Holdings Inc (ABP) Registers a 3.72 Increase, Closing at 0.22 - DWinneX

Jun 17, 2025

Jun 17, 2025

Unity Software Inc’s Market Journey: Closing Strong at 24.40, Up 3.13 - DWinneX

Jun 17, 2025

Jun 13, 2025

I-Mab Sponsored ADR (IMAB)'s Technical Outlook is Bright After Key Golden Cross - MSN

Jun 13, 2025

Jun 12, 2025

I-Mab regains Nasdaq compliance as shares maintain $1 minimum bid - Investing.com India

Jun 12, 2025

Jun 12, 2025

I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement - Yahoo Finance

Jun 12, 2025

Jun 11, 2025

Figure 1. Protein and mRNA expressions of P-glycoprotein in BEL-7402... - researchgate.net

Jun 11, 2025

Jun 11, 2025

Willdan Group, Inc.'s (NASDAQ:WLDN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - Yahoo Finance

Jun 11, 2025

Jun 11, 2025

Can This Unstoppable Stock Join Microsoft, Nvidia, Apple, Amazon, Alphabet, Meta Platforms, and Tesla in the $1 Trillion Club? - Yahoo Finance

Jun 11, 2025

Jun 10, 2025

Graphjet Technology Discloses Notice from Nasdaq - Yahoo Finance

Jun 10, 2025

Jun 07, 2025

B. Riley Financial granted extension from Nasdaq regarding listing rules - Yahoo Finance

Jun 07, 2025

Jun 06, 2025

I-Mab Sponsored ADR (IMAB) is a Great Momentum Stock: Should You Buy? - sharewise

Jun 06, 2025

Jun 06, 2025

All You Need to Know About PTC Therapeutics (PTCT) Rating Upgrade to Buy - Yahoo Finance

Jun 06, 2025

Jun 05, 2025

Asian Stocks Shine As Biotech And Financials Lead Gains - Finimize

Jun 05, 2025

Jun 05, 2025

Lyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study Success - Yahoo Finance

Jun 05, 2025

Jun 03, 2025

I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series - Yahoo Finance

Jun 03, 2025

May 28, 2025

I-Mab stock surges on Lucid Capital’s buy rating initiation By Investing.com - Investing.com South Africa

May 28, 2025

May 28, 2025

I-Mab stock surges on Lucid Capital’s buy rating initiation - Investing.com

May 28, 2025

May 28, 2025

Lucid Capital sets I-Mab stock Buy rating, $5 target on cancer drug potential - Investing.com

May 28, 2025

May 17, 2025

I-Mab’s Financial Report Highlights Givastomig Progress - TipRanks

May 17, 2025

May 15, 2025

I-Mab Reports First Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

May 15, 2025

May 06, 2025

I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023 - Barchart.com

May 06, 2025

May 05, 2025

I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC - Barchart.com

May 05, 2025

Apr 14, 2025

After Plunging -20.33% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB) - Yahoo Finance

Apr 14, 2025

Apr 11, 2025

After Plunging -19.7% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB) - Yahoo Finance

Apr 11, 2025

Apr 07, 2025

I-Mab at Needham Conference: Strategic Transformation Unveiled - Investing.com

Apr 07, 2025

Apr 07, 2025

I-Mab at Needham Conference: Strategic Transformation Unveiled By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 04, 2025

I-Mab’s Transformative Year: Financial and Strategic Highlights - TipRanks

Apr 04, 2025

Apr 04, 2025

I-Mab stock price target lowered to $7 at H.C. Wainwright By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

I-Mab stock price target lowered to $7 at H.C. Wainwright - Investing.com India

Apr 04, 2025

Apr 03, 2025

I-Mab stock touches 52-week low at $0.72 amid market challenges - Investing.com

Apr 03, 2025

Mar 21, 2025

I-Mab faces Nasdaq delisting over bid price rule By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

I-Mab faces Nasdaq delisting over bid price rule - Investing.com

Mar 21, 2025

Mar 07, 2025

I-Mab advances gastric cancer treatment with swift trial enrollment - Investing.com

Mar 07, 2025

Mar 05, 2025

I-Mab stock touches 52-week low at $0.76 amid market challenges - Investing.com India

Mar 05, 2025